ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005

Univ. Of Pittsburg distances Itself From Fisher

June 24, 1994

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997

NCI Seeks Prevention Fellows.

March 9, 2001

Cancer Act 25th Year: cancer Mortality Rate Began decline In 1990s, NCI, ACS Studies Find

November 22, 1996